Fluor provided EPCMV services for a $365 million pharmaceutical operations expansion program that included five major projects. Conceptual work, basic engineering, and detailed design were performed by Fluor with field support from our Cork, Ireland office.
The projects were a bulk-finishing facility, a multiproduct batch organic synthesis facility, two related organic synthesis facilities, and a CUB.
The largest facility completed by Fluor was a $132 million schedule-driven, bulk-finishing facility with multiple lines to produce 5.5 billion tablets per year, with future capacity for expansion. The 262,000-square-foot facility is among the largest tablet facilities in the world.
Fluor also completed the new $85 million, multiproduct batch organic synthesis facility that included a hydrogenation suite and multiple, glass-lined reactor systems.
The fast-track project was successfully completed in 27 months, and the first batch met specification. Final APIs for Lipitor are now supplied from this site.
Fluor also provided full project services for renovation of two related organic synthesis facilities at Cork and Little Island, Ireland. The fifth project was a $40 million central utilities building.